NASDAQ: FGNXFg Nexus Inc Stock
$5.95-0.45 (-7.03%)
Updated Jun 17, 2026
FGNX Price
$5.95
Fair Value Price
$4.05
Market Cap
$37.25M
52 Week Low
$4.18
52 Week High
$206.25
P/E
-1.41x
P/B
0.41x
P/S
1.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$17.52M
Earnings
-$95.62M
Gross Margin
59.7%
Operating Margin
-545.58%
Profit Margin
-555.4%
Debt to Equity
0.05
Operating Cash Flow
-$10M
Beta
0.76
Next Earnings
Aug 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A
FGNX Overview
FG Nexus Inc. specializes in providing reinsurance, asset management, and merchant banking services. The company was established in October 2012 and operates from its headquarters in Charlotte, NC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FGNX's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Life Insurance
Industry Rating
C
FGNX
Ranked#13 of 13
Ranked#13 of 13
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.28 | B | |
| $1.31 | B | |
| $13.14 | C |
Be the first to know about important FGNX news, forecast changes, insider trades & much more!
FGNX News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FGNX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FGNX ($5.95) is overvalued by 46.78% relative to our estimate of its Fair Value price of $4.05 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FGNX ($5.95) is not significantly undervalued (46.78%) relative to our estimate of its Fair Value price of $4.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FGNX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FGNX due diligence checks available for Premium users.
Valuation
FGNX fair value
Fair Value of FGNX stock based on Discounted Cash Flow (DCF)
Price
$5.95
Fair Value
$4.05
Overvalued by
46.78%
FGNX ($5.95) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FGNX ($5.95) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FGNX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
FGNX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.41x
Industry
14x
Market
12.4x
FGNX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.41x
Industry
1.47x
FGNX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FGNX's financial health
Profit margin
Revenue
$232.0k
Net Income
-$38.6M
Profit Margin
-16,808.6%
FGNX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$95.7M
Liabilities
$4.9M
Debt to equity
0.05
FGNX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
FGNX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$6.2M
Investing
$21.4M
Financing
-$14.4M
FGNX vs Life Insurance Stocks
Fg Nexus Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.